A report published in PharmoEconomics argues the case for registered reports to be taken up by health economic journals. Beyond the scientific benefits of registered reports in minimising the potential for publication bias, there is potentially an important efficiency gain. The authors argue that registered reports, in which the protocol is peer reviewed before the experiment has been conducted, will greatly mitigate bias and reduce research waste.
Open Clarke, P., Buckell, J. & Barnett, A. PharmacoEconomics Open (2020). https://doi.org/10.1007/s41669-019-00190-x